All Insights

Dispute resolution

Choice of courts: Are asymmetric jurisdiction clauses still a good idea post-Brexit?

Asymmetric jurisdiction clauses bring with them new risks in an EU context, to be weighed on a deal-by-deal basis –
Regulatory Outlook

Health and safety | UK Regulatory Outlook February 2023

Developers given six weeks to sign contract to fix unsafe buildings | Risks posed by falling trees | Building Safety
Regulatory Outlook

Products | UK Regulatory Outlook February 2023

Medical Technology Strategy | UK to introduce regulatory framework for point of care manufacturing | Commission launches call for evidence
Brexit

The UK Retained EU Law Bill: legislative havoc or promised post-Brexit deregulation?

As the House of Lords begins its second reading of the controversial bill, we look at what it does, what
Regulatory Outlook

Food law | UK Regulatory Outlook January 2023

New novel foods? | Genetically modified crops? | New timescales for HFSS products
Knowledge Notes

UK business law predictions for 2023

As the new year unfolds, we look ahead at what legal developments businesses can expect
The Built Environment

A look ahead for UK real estate in 2023

The new year will be a busy one – including the implementation of new regimes for overseas ownership of UK
Life Sciences and Healthcare

Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device

'Urgent need to get the regulation right' says RHC report which recommends an increase in regulatory capacity and capability to
Regulatory Outlook

Data protection | UK Regulatory Outlook November 2022

ICO publishes updated guidance on international data transfer requirements | UK government finalises South Korea data adequacy decision | Deadline
Regulatory Outlook

Products | UK Regulatory Outlook November 2022

Government further delays use of UK product safety marking | UK-wide packaging regulations expected to enter into force in late
Intellectual property

General Court finds UK evidence not admissible post-Brexit in EUIPO proceedings

Judgment disagrees with earlier decisions and rejects UK evidence despite pre-Brexit filing date of contested EU mark
Life Sciences and Healthcare

MHRA moves to assuage medical device manufacturers over UK's post-Brexit plans

Businesses will have more time to prepare for the new UKCA marking regime and comment on draft medical device regulations